FREE CONTACT HOUR: JHSON Virtual Nursing Grand Rounds
p{ margin:10px 0; padding:0; } table{ border-collapse:collapse; } h1,h2,h3,h4,h5,h6{ display:block; margin:0; padding:0; } img,a img{ border:0; height:auto; outline:none; text-decoration:none; } body,#bodyTable,#bodyCell{ height:100%; margin:0; padding:0; width:100%; } .mcnPreviewText{ display:none !important; } #outlook a{ padding:0; } img{ -ms-interpolation-mode:bicubic; } table{ mso-table-lspace:0pt; mso-table-rspace:0pt; } .ReadMsgBody{ width:100%; } .ExternalClass{ width:100%; } p,a,li,td,blockquote{ ...
Source: Johns Hopkins University and Health Systems Archive - August 10, 2022 Category: Nursing Source Type: news

Rwanda: Hepatitis - Rwanda on Course to Reach Last Mile
[New Times] The first time Alice Mukabalisa, 53, discovered that she had hepatitis was when she went to take a vaccination shot in 2018. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 5, 2022 Category: African Health Source Type: news

Ghana: 'Ensure Hepatitis Vaccination At Birth'
[Ghanaian Times] A Consultant Gastroenterologist and Physician, DrAdwoaAgyei-Nkansah, has appealed to government to ensure Hepatitis vaccination at birth in the country. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 4, 2022 Category: African Health Source Type: news

The Virus Hunters Trying to Prevent the Next Pandemic
Nobody saw SARS-CoV-2 coming. In the early days of the pandemic, researchers were scrambling to collect samples from people who had mysteriously developed fevers, coughs, and breathing problems. Pretty soon, they realized that the disease-causing culprit was a new virus humans hadn’t seen before. And the world, lacking a coordinated global response, was unprepared. Some countries acted quickly to develop tests for the novel coronavirus, while others with fewer resources were left behind. With a virus oblivious to national borders, and with travel between countries and continents more common than it had been in previo...
Source: TIME: Health - August 1, 2022 Category: Consumer Health News Authors: Alice Park and Video by Andrew D. Johnson Tags: Uncategorized Disease Frontiers of Medicine 2022 healthscienceclimate Source Type: news

Progress Toward the Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Worldwide, 2016-2021
This report describes global progress towards the elimination of mother-to-child hepatitis B virus. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 28, 2022 Category: American Health Tags: Hepatitis B Hepatitis B Vaccination MMWR Morbidity & Mortality Weekly Report Source Type: news

Ghana: World Hepatitis Day, July 28 (1)
[Ghanaian Times] The burden of hepatitis B infection is highest in the WHO Western Pacific Region and the WHO African Region, where 116 million and 81 million people, respectively, are chronically infected. In 2019, hepatitis B resulted in an estimated 820 000 deaths, mostly from cirrhosis and hepatocellular carcinoma (primary liver cancer). Hepatitis B can be prevented by vaccines that are safe, available and effective. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 28, 2022 Category: African Health Source Type: news

CDC Endorses Novavax COVID-19 Shot for Adults
U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax—a more traditional kind of vaccine, health officials said Tuesday. Regulators authorized the nation’s first so-called protein vaccine against COVID-19 last week, but the final hurdle was a recommendation from the Centers for Disease Control and Prevention. “If you have been waiting for a COVID-19 vaccine built on a different technology than those previously available, now is the time to join the millions of Americans who have been vaccinated,” Dr. Rochelle Walensky, CDC’s director, said in a s...
Source: TIME: Health - July 20, 2022 Category: Consumer Health News Authors: Lauran Neergaard / AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news

Why You ’ ll Need to Get COVID-19 Boosters Again and Again
Several highly effective vaccines were developed at an unprecedented speed to combat the COVID-19 pandemic. During the phase 3 clinical trials, mRNA vaccines had vaccine efficacy of 94–95% in preventing symptomatic infections. After the rollout, real-world evidence showed that the mRNA vaccines provided ~90% effectiveness against infection. Then came the variants. The wave after wave of new variants, with ever-increasing transmissibility and capacity to escape existing immunity, challenge the ability of vaccines to prevent infection and transmission. The effectiveness of a primary series of mRNA vaccines (two doses) ...
Source: TIME: Health - July 19, 2022 Category: Consumer Health News Authors: Akiko Iwasaki and Albert Ko Tags: Uncategorized COVID-19 freelance Source Type: news

How COVID-19 Vaccines May Affect Periods
When clinical trials began testing the various COVID-19 vaccines, one question participants weren’t asked about was whether they experienced any changes to their menstrual cycles or unexpected bleeding after getting vaccinated. Soon after the vaccines were rolled out to the public, however, people began talking to their doctors about what they were experiencing. Many had noticed that their periods had become heavier than normal. Initially, some clinicians were dismissive, write the authors of a new survey on the topic published in the journal Science Advances. “In media coverage, medical doctors and public heal...
Source: TIME: Health - July 18, 2022 Category: Consumer Health News Authors: Kyla Mandel Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Roche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virus
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.TheElecsys HCVDuo immunoassay enables significantly earlier diagnosis of active HCV infection, making it possible to get patients appropriate care sooner to stop both the disease progression and transmission.Basel, 18 July 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Elecsys ® HCV Duo immunoassay in countries that accept the CE Mark. Elecsys HCV Duo is the first available immunoassay that allows the simultaneous ...
Source: Roche Investor Update - July 18, 2022 Category: Pharmaceuticals Source Type: news

Roche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virus
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.TheElecsys HCVDuo immunoassay enables significantly earlier diagnosis of active HCV infection, making it possible to get patients appropriate care sooner to stop both the disease progression and transmission.Basel, 18 July 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Elecsys ® HCV Duo immunoassay in countries that accept the CE Mark. Elecsys HCV Duo is the first available immunoassay that allows the simultaneous ...
Source: Roche Media News - July 18, 2022 Category: Pharmaceuticals Source Type: news

FREE CONTACT HOUR: JHSON Virtual Nursing Grand Rounds
p{ margin:10px 0; padding:0; } table{ border-collapse:collapse; } h1,h2,h3,h4,h5,h6{ display:block; margin:0; padding:0; } img,a img{ border:0; height:auto; outline:none; text-decoration:none; } body,#bodyTable,#bodyCell{ height:100%; margin:0; padding:0; width:100%; } .mcnPreviewText{ display:none !important; } #outlook a{ padding:0; } img{ -ms-interpolation-mode:bicubic; } table{ mso-table-lspace:0pt; mso-table-rspace:0pt; } .ReadMsgBody{ width:100%; } .ExternalClass{ width:100%; } p,a,li,td,blockquote{ ...
Source: Johns Hopkins University and Health Systems Archive - July 13, 2022 Category: Nursing Source Type: news

Safety, Response to Inactivated COVID-19 Vaccine in Chronic HBV Safety, Response to Inactivated COVID-19 Vaccine in Chronic HBV
Are inactivated COVID-19 vaccines well tolerated in patients with chronic hepatitis B infection, and do they induce an effective antibody response?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 12, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

South Korea Approves First Domestically Developed COVID-19 Vaccine
SEOUL, South Korea — Health officials in South Korea on Wednesday approved the country’s first domestically developed COVID-19 vaccine for people 18 years or older, adding another public health tool in the fight against a prolonged pandemic. In clinical trials involving some 4,000 participants in South Korea and five other countries, SK Bioscience’s two-dose SKYCovione vaccine appeared to be more effective than the broadly used AstraZeneca shots in building immunity against infections, officials at South Korea’s Food and Drug Safety Ministry said. It isn’t immediately clear how officials will ...
Source: TIME: Health - June 29, 2022 Category: Consumer Health News Authors: Kim Tong-hyung / AP Tags: Uncategorized COVID-19 overnight wire Source Type: news

Wisconsin SeniorCare Program to Cover Vaccines Provided at Pharmacies
Gov. Tony Evers and the Wisconsin Department of Health Services (DHS) announce Wisconsin ’s SeniorCare Program has received approval from the Centers for Medicare& Medicaid Services (CMS) to cover certain vaccines that members receive in pharmacies. Vaccines covered include those that protect against shingles, tetanus, meningitis, and Hepatitis A and B. These vaccines are recommended by theAdvisory Committee on Immunization Practices...(see release) (Source: Wisconsin DHFS Press Releases)
Source: Wisconsin DHFS Press Releases - June 27, 2022 Category: Hospital Management Authors: millejcodn Source Type: news